+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Serum-Free Media Market by Product, Type, End-User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6012648
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Serum-Free Media Market grew from USD 1.52 billion in 2023 to USD 1.68 billion in 2024. It is expected to continue growing at a CAGR of 11.35%, reaching USD 3.23 billion by 2030.

Serum-free media (SFM) is a pivotal innovation in cell culture, designed to eliminate animal-derived components, particularly fetal bovine serum, to improve the consistency and safety of biomedical applications. The necessity for SFM arises from the need to mitigate variability and contamination risks associated with serum, enhance reproducibility in research, and comply with strict regulatory norms especially in biopharmaceutical production. SFM finds extensive application in biopharmaceuticals, vaccine production, regenerative medicine, and cancer research. Its end-use scope spans across pharmaceutical companies, research laboratories, and hospitals. The growth of the SFM market is largely influenced by the increasing demand for biologics, advancements in biotechnology, and the rising ethical concerns related to animal welfare. Furthermore, the surge in personalized medicine and cell-based therapeutics presents immense opportunities. To capitalize on these opportunities, companies could focus on developing robust and cost-effective formulations tailored for specific cell types and applications. However, challenges such as high production costs, technical complexities in formulation, and resistance to change from traditional serum-based systems may hinder market growth. Innovations and research in formulating universal SFMs, improving scalability, and enhancing cell growth performance can provide substantial competitive advantages. Additionally, expanding collaborations with academic and industrial players to accelerate product development and streamline the regulatory approval process could foster market expansion. The industry is characterized by rapid technological advancements, necessitating continuous improvements and staying abreast of emerging trends. Thus, the key to business growth lies in strategic investments in research and development, leveraging advances such as AI in optimizing media components, and exploring novel applications in regenerative medicine and tissue engineering. Addressing limitations, such as formulation cost and variability, through technological innovations is crucial for sustaining competitive differentiation in the dynamic SFM market.

Understanding Market Dynamics in the Serum-Free Media Market

The Serum-Free Media Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing production of monoclonal antibodies, vaccines, and recombinant proteins
    • Rising government investment and initiatives for stem cell research
  • Market Restraints
    • Nutrient limitations and reduced cell proliferation
  • Market Opportunities
    • Collaboration among academia and biotech firms to customize serum-free media products
    • Advancements in bioprocess technology and analytical tools
  • Market Challenges
    • Complexity of designing and optimizing serum-free media

Exploring Porter’s Five Forces for the Serum-Free Media Market

Porter’s Five Forces framework further strengthens the insights of the Serum-Free Media Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Serum-Free Media Market

External macro-environmental factors deeply influence the performance of the Serum-Free Media Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Serum-Free Media Market

The Serum-Free Media Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Serum-Free Media Market

The Serum-Free Media Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Serum-Free Media Market

The Serum-Free Media Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Serum-Free Media Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., ATZ Labz by Life Technologies (India) Pvt Ltd., Becton, Dickinson and Company, Bio-Techne Corporation, Biowest, Celprogen Inc., Corning Incorporated, Danahar Corporation, FUJIFILM Holdings Corporation, Fukoku Co., Ltd., Gmep Incorporated, HiMedia Laboratories., Jimi Biotech, Kyokuto Pharmaceutical Industrial Co., Ltd, Leinco Technologies, Inc., Lonza Group, Merck KgaA, Myoridge Co. Ltd., Nucleus Biologics, PAN-Biotech GmbH, R&D Systems, Inc., REPROCELL Inc., Sartorius AG, Shanghai BioEngine Sci-Tech Co, Ltd, Shanghai Excell Biological Technology Co., Ltd., Sino Biological, Inc., STEMCELL Technologies Canada Inc., Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd., and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the Serum-Free Media Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • BHK Medium
    • CHO Media
    • HEK 293 Media
    • Stem Cell Medium
    • Vero Medium
  • Type
    • Liquid Media
    • Semi-solid & Solid Media
  • End-User
    • Pharmaceutical & Biotechnology Companies
    • Research & Academic Institutes
  • Application
    • Biopharmaceutical Production
      • Monoclonal Antibodies
      • Vaccines Production
    • Tissue Engineering & Regenerative Medicine
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing production of monoclonal antibodies, vaccines, and recombinant proteins
5.1.1.2. Rising government investment and initiatives for stem cell research
5.1.2. Restraints
5.1.2.1. Nutrient limitations and reduced cell proliferation
5.1.3. Opportunities
5.1.3.1. Collaboration among academia and biotech firms to customize serum-free media products
5.1.3.2. Advancements in bioprocess technology and analytical tools
5.1.4. Challenges
5.1.4.1. Complexity of designing and optimizing serum-free media
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Serum-Free Media Market, by Product
6.1. Introduction
6.2. BHK Medium
6.3. CHO Media
6.4. HEK 293 Media
6.5. Stem Cell Medium
6.6. Vero Medium
7. Serum-Free Media Market, by Type
7.1. Introduction
7.2. Liquid Media
7.3. Semi-solid & Solid Media
8. Serum-Free Media Market, by End-User
8.1. Introduction
8.2. Pharmaceutical & Biotechnology Companies
8.3. Research & Academic Institutes
9. Serum-Free Media Market, by Application
9.1. Introduction
9.2. Biopharmaceutical Production
9.2.1. Monoclonal Antibodies
9.2.2. Vaccines Production
9.3. Tissue Engineering & Regenerative Medicine
10. Americas Serum-Free Media Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Serum-Free Media Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Serum-Free Media Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. SERUM-FREE MEDIA MARKET RESEARCH PROCESS
FIGURE 2. SERUM-FREE MEDIA MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. SERUM-FREE MEDIA MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. SERUM-FREE MEDIA MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. SERUM-FREE MEDIA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SERUM-FREE MEDIA MARKET DYNAMICS
TABLE 7. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BHK MEDIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY CHO MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY HEK 293 MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL MEDIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VERO MEDIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY LIQUID MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY SEMI-SOLID & SOLID MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY VACCINES PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 41. CANADA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. CANADA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. CANADA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 68. CHINA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. CHINA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. CHINA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. CHINA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. CHINA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 73. INDIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. INDIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. INDIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. INDIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 83. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 113. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 134. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 139. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 144. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 149. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 159. ITALY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. ITALY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. ITALY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. ITALY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. ITALY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 174. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 179. POLAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. POLAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. POLAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. POLAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. POLAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 184. QATAR SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. QATAR SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. QATAR SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 204. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 219. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 234. SERUM-FREE MEDIA MARKET SHARE, BY KEY PLAYER, 2023
TABLE 235. SERUM-FREE MEDIA MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Serum-Free Media market, which are profiled in this report, include:
  • Ajinomoto Co., Inc.
  • ATZ Labz by Life Technologies (India) Pvt Ltd.
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Biowest
  • Celprogen Inc.
  • Corning Incorporated
  • Danahar Corporation
  • FUJIFILM Holdings Corporation
  • Fukoku Co., Ltd.
  • Gmep Incorporated
  • HiMedia Laboratories.
  • Jimi Biotech
  • Kyokuto Pharmaceutical Industrial Co., Ltd
  • Leinco Technologies, Inc.
  • Lonza Group
  • Merck KgaA
  • Myoridge Co. Ltd.
  • Nucleus Biologics
  • PAN-Biotech GmbH
  • R&D Systems, Inc.
  • REPROCELL Inc.
  • Sartorius AG
  • Shanghai BioEngine Sci-Tech Co, Ltd
  • Shanghai Excell Biological Technology Co., Ltd.
  • Sino Biological, Inc.
  • STEMCELL Technologies Canada Inc.
  • Thermo Fisher Scientific Inc.
  • TransGen Biotech Co., Ltd.
  • ZenBio, Inc.

Methodology

Loading
LOADING...

Table Information